Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

May 2015

More Than Guidelines: Safe Handling in Everyday Practice

ByLisa Schulmeister, MN, RN, ANCS-BC, OCN, FAAN
May 22nd 2015

Although safe handling guidelines have been published by several organizations, their adoption remains elusive.

Reducing Central Line-Associated Bloodstream Infections

ByLisa Truini-Pittman, RN, BSN, MPH, OCN, Linda Sullivan, RN, Kirsten Pedersen, RN, BSN, OCN, Tanaz Mistry, RN, BSN, OCN, NP,Jill Williams, RN, BSN, NP
May 15th 2015

Decreasing hospital associated infection rates including Central Line–Associated Bloodstream Infections is an issue of ongoing focus nationwide.

Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Approves Iberdomide for Relapsed or Refractory Multiple Myeloma

2

Prostate Cancer Risk Factors Do Not Predict Hormone Therapy Benefit

3

How Iberdomide Approval Benefits Rural and Frail Multiple Myeloma Patients

4

FDA Approves OncoSil Device for Unresectable Distal Cholangiocarcinoma

5

Advancing Frontline Treatment in Metastatic Triple-Negative Breast Cancer with ADCs

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us